ALCOA+ violations, audit trail gaps, and 21 CFR Part 11 electronic records findings.
This page describes FDA inspection findings for this GMP topic. Search the full, interactive database on the 483 Signal dashboard.
We use essential cookies to make our site work and analytics cookies to understand how you use it. By continuing to use this site, you agree to our use of cookies. Learn more